A new trading day began on Tuesday, with 2seventy bio Inc (NASDAQ: TSVT) stock price up 4.83% from the previous day of trading, before settling in for the closing price of $4.97. TSVT’s price has ranged from $1.53 to $6.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 73.45% over the past five years. Meanwhile, its annual earnings per share averaged 81.28%. With a float of $48.21 million, this company’s outstanding shares have now reached $50.63 million.
Let’s look at the performance matrix of the company that is accounted for 274 employees. In terms of profitability, gross margin is 48.16%, operating margin of -468.86%, and the pretax margin is -354.16%.
2seventy bio Inc (TSVT) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of 2seventy bio Inc is 6.38%, while institutional ownership is 92.50%. The most recent insider transaction that took place on Aug 14 ’24, was worth 33,760. In this transaction an insider of this company sold 7,816 shares at a rate of $4.32, taking the stock ownership to the 156,330 shares. Before that another transaction happened on Aug 14 ’24, when Company’s Officer proposed sale 7,816 for $4.32, making the entire transaction worth $33,760.
2seventy bio Inc (TSVT) Latest Financial update
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -1.4 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 81.28% per share during the next fiscal year.
2seventy bio Inc (NASDAQ: TSVT) Trading Performance Indicators
Here are 2seventy bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.06, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.36 in one year’s time.
Technical Analysis of 2seventy bio Inc (TSVT)
2seventy bio Inc (NASDAQ: TSVT) saw its 5-day average volume 0.27 million, a negative change from its year-to-date volume of 0.8 million. As of the previous 9 days, the stock’s Stochastic %D was 76.09%. Additionally, its Average True Range was 0.25.
During the past 100 days, 2seventy bio Inc’s (TSVT) raw stochastic average was set at 94.89%, which indicates a significant increase from 87.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 29.39% in the past 14 days, which was lower than the 64.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.72, while its 200-day Moving Average is $4.61. Nevertheless, the first resistance level for the watch stands at $5.37 in the near term. At $5.53, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.76. If the price goes on to break the first support level at $4.98, it is likely to go to the next support level at $4.75. The third support level lies at $4.59 if the price breaches the second support level.
2seventy bio Inc (NASDAQ: TSVT) Key Stats
With a market capitalization of 268.32 million, the company has a total of 51,405K Shares Outstanding. Currently, annual sales are 100,390 K while annual income is -217,570 K. The company’s previous quarter sales were 8,970 K while its latest quarter income was 24,880 K.
